Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 11 November 2021
First Online: 18 November 2021
Declarations
:
: LL is coinventor on the International Patent (WO/2020/226993) filed in April 2020 and relating to the use of antibodies which specifically bind IL-1α to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. The other authors report no conflict of interest.
